WASHINGTON, D.C. (WANE) The Food and Drug Administration (FDA) on Wednesday issued a request for the removal of all prescription and over-the-counter (OTC) ranitidine drugs commonly known as Zantac ...

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK ...

Apotex Corp. is voluntarily, on a precautionary basis, recalling Ranitidine Tablets 75mg and 150mg (All pack sizes and Formats) to the Retail level. Apotex has learned from the U.S. Food and Drug ...

The U.S. FDA has approved reformulated ranitidine tablets, marking the reintroduction of this widely used H2 receptor antagonist following extensive regulatory review and updated ...

Zantac 75 relief is an effective antacid that has Ranitidine as one of its chief ingredients. Ranitidine is one of the most effective antacids available in the market place and is extremely effective ...

Feb 1 (Reuters) - GSK (GSK.L), opens new tab said on Thursday it had agreed to settle another lawsuit in California that alleged its discontinued heartburn drug Zantac caused cancer, the latest in a ...

WASHINGTON — The U.S. Food and Drug Administration has approved a reformulated version of ranitidine, which was sold widely under the brand name Zantac, allowing the acid-reducing drug to return to ...

WASHINGTON, D.C. – The U.S. Food and Drug Administration (FDA) is requesting that manufacturers immediately pull all prescription and over-the-counter (OTC) ranitidine drugs from the market. The ...

Cancer affects roughly one in three women and one in three men in the United States, and last year, there were an estimated 1,762,450 new cases of cancer reported on record. While the types of cancer ...